Overview Efficacy and Safety of Resatorvid in Patients With Sepsis-induced Cardiovascular and Respiratory Failure Status: Terminated Trial end date: 2009-02-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine the effect of resatorvid on subjects with sepsis. Phase: Phase 3 Details Lead Sponsor: Takeda